Diet and Its Role in Bladder Pain Syndrome and Comorbid Conditions

  • Justin I. Friedlander
  • Barbara Shorter
  • Robert M. Moldwin


Many patients with Bladder Pain Syndrome (BPS) have sensitivities to various comestibles. There are a variety of pathologic mechanisms suggested to be responsible for the relationship between dietary intake and symptom exacerbation. Based upon the current literature, certain food types affect symptoms of BPS and comorbid conditions more than others, suggesting that a controlled method to determine dietary sensitivities, such as the elimination diet, may play an important first-line role in the management of the BPS patient. When considering dietary intervention in patients with BPS, it is of utmost importance to take into account comorbid conditions when counseling patients.


Neuropathic Pain Irritable Bowel Syndrome Chronic Fatigue Syndrome Carpal Tunnel Syndrome Irritable Bowel Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Bladder pain syndrome


Chronic fatigue syndrome


Fibromyalgia syndrome




Irritable bowel syndrome


Interstitial cystitis


Interstitial Cystitis Association


O’Leary–Sant pain index


Pain urgency, frequency scale


  1. 1.
    Buffington CA. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol. 2004;172:1242.PubMedCrossRefGoogle Scholar
  2. 2.
    Erickson DR, Morgan KC, Ordille S, et al. Nonbladder related symptoms in patients with interstitial cystitis. J Urol. 2001;166:557.PubMedCrossRefGoogle Scholar
  3. 3.
    Jones CA, Nyberg L. Epidemiology of interstitial cystitis. Urology. 1997;49:2.PubMedCrossRefGoogle Scholar
  4. 4.
    Rodríguez MB, Afari N, Buchwald DS. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2009;182:2123.PubMedCrossRefGoogle Scholar
  5. 5.
    Parsons CL. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology. 2007;69:9.PubMedCrossRefGoogle Scholar
  6. 6.
    Hauser PJ, Dozmorov MG, Bane BL, et al. Abnormal expression of differentiation related proteins in the urothelium of patients with interstitial cystitis. J Urol. 2008;179:764.PubMedCrossRefGoogle Scholar
  7. 7.
    Hurst RE, Moldwin RM, Mulholland SG. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Urology. 2007;69:17.PubMedCrossRefGoogle Scholar
  8. 8.
    Ustinova EE, Fraser MO, Pezzone MA. Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn. 2010;29:77.PubMedCrossRefGoogle Scholar
  9. 9.
    Rudick CN, Chen MC, Monglu AK, et al. Organ cross talk modulates pelvic pain. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1191.PubMedCrossRefGoogle Scholar
  10. 10.
    Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis. Urology. 2007;69:24.PubMedCrossRefGoogle Scholar
  11. 11.
    Wesselmann U. Neurogenic inflammation and chronic pelvic pain. World J Urol. 2001;3:180.CrossRefGoogle Scholar
  12. 12.
    Shorter B, Lesser M, Moldwin R, et al. Effect of comestibles on symptoms of interstitial cystitis. J Urol. 2007;178:145.PubMedCrossRefGoogle Scholar
  13. 13.
    Gillespie L. You don’t have to live with cystitis! New York: Rawson Associates; 1996.Google Scholar
  14. 14.
    Koziol JA, Clark DC, Gittes RF, et al. The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993;149:465.PubMedGoogle Scholar
  15. 15.
    Nguan C, Franciosi LG, Butterfield N, et al. A prospective, double-blind, randomized cross-over study evaluating changes in urinary pH for relieving the symptoms of interstitial cystitis. BJU Int. 2005;95:91.PubMedCrossRefGoogle Scholar
  16. 16.
    Clemens JQ, Brown SO, Kosloff L, et al. Predictors of symptoms severity in patients with chronic prostatitis and interstitial cystitis. J Urol. 2006;175:963.PubMedCrossRefGoogle Scholar
  17. 17.
    Yamada T. Significance of complications of allergic diseases in young patients with interstitial cystitis. Int J Urol. 2003;10:S56.PubMedCrossRefGoogle Scholar
  18. 18.
    Bologna RA, Gomelsky A, Lukban JC, Whitmore KE, et al. The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis. Urology. 2001;57(6):119.PubMedCrossRefGoogle Scholar
  19. 19.
    Theoharides TC, Sant GR. A pilot open label study of cystoprotek in interstitial cystitis. Int J Immunopathol Pharmacol. 2005;18:183.PubMedGoogle Scholar
  20. 20.
    Gettman MT, Ogan K, Brinkley LJ, et al. Effect of cranberry juice consumption on urinary stone risk factors. J Urol. 2005;174:590.PubMedCrossRefGoogle Scholar
  21. 21.
    Marinkovic SP, Moldwin R, Gillen LM, et al. The management of interstitial cystitis or painful bladder syndrome in women. BMJ. 2009;339:337.CrossRefGoogle Scholar
  22. 22.
    Parsons CL, Greene RA, Chung M, et al. Abnormal urinary potassium metabolism in patients with interstitial cystitis. J Urol. 2005;173:1182.PubMedCrossRefGoogle Scholar
  23. 23.
    Parsons CL, Greenberger M, Gabal L, et al. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol. 1998;159:1862.PubMedCrossRefGoogle Scholar
  24. 24.
    Parsons CL, Zupkas P, Parsons JK. Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. Urology. 2001;57:428.PubMedCrossRefGoogle Scholar
  25. 25.
    Gillespie L. Metabolic appraisal of the effects of dietary modifications on hypersensitive bladder symptoms. Br J Urol. 1992;72:293.Google Scholar
  26. 26.
    Bird ET, Parker BD, Kim HS, et al. Caffeine ingestion and lower urinary tract symptoms in healthy volunteers. Neurourol Urodyn. 2005;24:611.PubMedCrossRefGoogle Scholar
  27. 27.
    Osborne J. Wine, beer & spirits – do they trigger IC flares? A patient survey reveals surprising results. IC Optimist. 2010;7:15.Google Scholar
  28. 28.
    Bassaly R, Downes K, Hart S. Dietary consumption triggers in interstitial cystitis/bladder pain syndrome patients. Female Pelvic Med Reconstr Surg. 2011;17:36.PubMedCrossRefGoogle Scholar
  29. 29.
    Clemens JQ, Meenan RT, O’KeeffeRosetti MC, et al. Case–control study of medical comorbidities in women with interstitial cystitis. J Urol. 2008;179(6):2222.PubMedCrossRefGoogle Scholar
  30. 30.
    Rodríguez MA, Afari N, Buchwald DS, National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Urological Chronic Pelvic Pain. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2009;182:2123.PubMedCrossRefGoogle Scholar
  31. 31.
    Mahan L, Escott-Stump S. Krause’s food and nutrition therapy. St. Louis: Saunders; 2008.Google Scholar
  32. 32.
    Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol. 2004;146:1.PubMedCrossRefGoogle Scholar
  33. 33.
    Heizer WD, Southern S, McGovern S. The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review. J Am Diet Assoc. 2009;109:1204.PubMedCrossRefGoogle Scholar
  34. 34.
    Bijkerk CJ, de Wit NJ, Muris JW, et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ. 2009;339:b3154.PubMedCrossRefGoogle Scholar
  35. 35.
    Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case–control study of interstitial cystitis/painful bladder syndrome. Urology. 2009;73:52.PubMedCrossRefGoogle Scholar
  36. 36.
    Heitkemper M, Jarrett M. Overlapping conditions in women with irritable bowel syndrome. Urol Nurs. 2005;25:25.PubMedGoogle Scholar
  37. 37.
    Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160.PubMedCrossRefGoogle Scholar
  38. 38.
    Nimnuan C, Rabe-Hesketh S, Wessely S, et al. How many functional somatic syndromes? J Psychosom Res. 2001;51:549.PubMedCrossRefGoogle Scholar
  39. 39.
    Haugen M, Kjeldsen-Kragh J, Nordvåg BY, et al. Diet and disease symptoms in rheumatic diseases–results of a questionnaire based survey. Clin Rheumatol. 1991;10:401.PubMedCrossRefGoogle Scholar
  40. 40.
    Holton KF, Kindler LL, Jones KD. Potential dietary links to central sensitization in fibromyalgia: past reports and future directions. Rheum Dis Clin North Am. 2009;35:409.PubMedCrossRefGoogle Scholar
  41. 41.
    Arranz LI, Canela MA, Rafecas M. Fibromyalgia and nutrition, what do we know? Rheumatol Int. 2010;30:1417.PubMedCrossRefGoogle Scholar
  42. 42.
    Nickel JC, Tripp DA, Pontari M, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol. 2010;184:1358.PubMedCrossRefGoogle Scholar
  43. 43.
    Fukuda K, Straus SE, Hickle I, et al. The chronic fatigue syndrome; a comprehensive approach to its definition and study. Ann Intern Med. 1994;121:953.PubMedGoogle Scholar
  44. 44.
    Logan AC, Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev. 2001;6:450.PubMedGoogle Scholar
  45. 45.
    Brouwers FM, Van Der Wef S, Bleijenberg G, et al. The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind randomized controlled trial. Q J Med. 2002;95:677.CrossRefGoogle Scholar
  46. 46.
    Teitelbaum JE, Johnson C, St Cyr J. The use of d-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med. 2006;12:857.PubMedCrossRefGoogle Scholar
  47. 47.
    Moldwin R. The interstitial cystitis survival guide. Oakland: New Harbinger; 2000.Google Scholar
  48. 48.
    Dell JR, Mokrzycki ML, Jayne CJ. Differentiating interstitial cystitis from similar conditions commonly seen in gynecologic practice. Eur J Obstet Gynecol Reprod Biol. 2009;144:105.PubMedCrossRefGoogle Scholar
  49. 49.
    Carrico DJ, Sherer KL, Peters KM. The relationship of interstitial cystitis/painful bladder syndrome to vulvodynia. Urol Nurs. 2009;29:233.PubMedGoogle Scholar
  50. 50.
    Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia; a historical perspective. J Reprod Med. 2004;49:772.PubMedGoogle Scholar
  51. 51.
    Solomons CC, Melmed MH, Heitler SM. Calcium citrate for vulvar vestibulitis. A case report. J Reprod Med. 1991;36:879.PubMedGoogle Scholar
  52. 52.
    Baggish MS, Sze EH, Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol. 1997;177:509.CrossRefGoogle Scholar
  53. 53.
    Harlow BL, Abenhaim HA, Vitonis AF, et al. Influence of dietary oxalates on the risk of adult-onset vulvodynia. J Reprod Med. 2008;53:171.PubMedGoogle Scholar
  54. 54.
    Novi JM, Jeronis S, Srinivas S, et al. Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case–control study. J Urol. 2005;174:937.PubMedCrossRefGoogle Scholar
  55. 55.
    Stahl LA, Begg DP, Weisinger RE, et al. The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs. 2008;9:57.PubMedGoogle Scholar
  56. 56.
    Dinan T, Siggins L, Scully P, et al. Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. J Psychiatr Res. 2009;43:471.PubMedCrossRefGoogle Scholar
  57. 57.
    Treede RD, Jensen TS, Campbell JN, et al. Redefinition of neuropathic pain and a grading system for clinical use; consensus statement on clnical and research diagnostic criteria. Neurology. 2008;70:1630.PubMedCrossRefGoogle Scholar
  58. 58.
    Ko GD, Nowacki NB, Arseneau L, et al. Omega-3 fatty acids for neuropathic pain: case series. Clin J Pain. 2010;26:168.PubMedCrossRefGoogle Scholar
  59. 59.
    Gormsen L, Rosenberg R, Bach FW, et al. Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain. 2010;14:127.PubMedCrossRefGoogle Scholar
  60. 60.
    Jansen SC, van Dusseldorp M, Botterna KC, et al. Intolerance to dietary biogenic amines: a review. Ann Allergy Asthma Immunol. 2003;91:233.PubMedCrossRefGoogle Scholar
  61. 61.
    Schiapparelli P, Allais G, Castagnoli Gabellari I, et al. Non-pharmacological approach to migraine prophylaxs: part II. Neurol Sci. 2010;31:S137.PubMedCrossRefGoogle Scholar
  62. 62.
    Alpay K, Ertas M, Orhan EK, et al. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia. 2010;30:829.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Justin I. Friedlander
    • 1
  • Barbara Shorter
    • 2
  • Robert M. Moldwin
    • 3
    • 4
  1. 1.The Arthur Smith Institute for Urology, North Shore-Long Island Jewish Health SystemNew Hyde ParkUSA
  2. 2.Didactic Program in Dietetics, Department of NutritionLong Island UniversityBrookvilleUSA
  3. 3.Urology DivisionThe Arthur Smith Institute for Urology, North Shore-Long Island Jewish Health SystemNew Hyde ParkUSA
  4. 4.Urology DepartmentThe Hofstra University School of MedicineNew Hyde ParkUSA

Personalised recommendations